Drug may be alternative to castration

Aug 23, 2006

U.S. medical scientists have found an oral drug is an acceptable alternative to chemical castration to treat prostate cancer.

"In patients with locally-advanced disease, a daily 150 mg dose of bicalutamide (Casodex) following initial radiotherapy has shown significant clinical benefits in terms of overall survival and progression-free survival, compared with radiotherapy alone," said study author Dr. William See, chairman and professor of urology at the Medical College of Wisconsin and chief of urologic surgery at Milwaukee's Froedtert Hospital.

The double-blind, randomized study followed 1,370 early prostate cancer patients who received radiotherapy with curative intent. After a median follow-up of 7.2 years, the researchers found those receiving the daily Casodex regimen reduced their risk of disease progression by 44 percent, and overall risk of death by 35 percent, compared with those receiving a placebo.

"Although many of the adverse effects of castration therapy are manageable, they can have a detrimental effect on quality of life," said See "Here we have evaluated the efficacy and tolerability of a non-castration-based therapy, and found the survival rates to be similar."

The study appears in the Journal of Cancer Research and Clinical Oncology.

Copyright 2006 by United Press International

Explore further: Scientists discover an on/off switch for aging cells

add to favorites email to friend print save as pdf

Related Stories

From graphite to water

Sep 17, 2013

Scientists from the National Physical Laboratory (NPL), in collaboration with researchers in Belgium and Italy, have published research that could help provide a primary standard for dose measurements of ...

Cryopreservation: A chance for highly endangered mammals

Feb 28, 2013

Oocytes of lions, tigers and other cat species survive the preservation in liquid nitrogen. Scientists of the Leibniz Institute for Zoo and Wildlife Research (IZW) in Berlin succeeded in carrying out cryopreservation ...

Recommended for you

Scientists discover an on/off switch for aging cells

Sep 20, 2014

(Medical Xpress)—Scientists at the Salk Institute have discovered an on-and-off "switch" in cells that may hold the key to healthy aging. This switch points to a way to encourage healthy cells to keep dividing ...

Sierra Leone faces criticism over Ebola shutdown

Sep 20, 2014

Sierra Leone began the second day of a 72-hour nationwide shutdown aimed at containing the spread of the deadly Ebola virus on Saturday amid criticism that the action was a poorly planned publicity stunt.

Vitamin K antagonist plus clopidogrel feasible for PCI

Sep 19, 2014

(HealthDay)—Vitamin K antagonists (VKA) combined with clopidogrel may be a better alternative to triple anticoagulant therapy in patients on long-term VKA undergoing percutaneous coronary intervention (PCI) ...

Electronic health records tied to shorter time in ER

Sep 19, 2014

(HealthDay)—Length of emergency room stay for trauma patients is shorter with the use of electronic health records, according to a study published in the September issue of the Journal of Emergency Nursing.

User comments : 0